The first in a number of high-profile UK Covid-19 business interruption disputes slated for 2022 begins next week in a trial which observers hope may bring greater certainty around coverage issues relating to so-called “denial of access” cover.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: